Comparative Safety and Health Care Expenditures Among Patients With Chronic Myeloid Leukemia Initiating First-Line Imatinib, Dasatinib, or Nilotinib
Cole, Ashley L., Wood, William A., Muluneh, Benyam, Lund, Jennifer L., Elston Lafata, Jennifer, Dusetzina, Stacie B.Language:
english
Journal:
JCO Oncology Practice
DOI:
10.1200/jop.19.00301
Date:
March, 2020
File:
PDF, 1.41 MB
english, 2020